Series A

With a fresh $17M from investors including CVS Health Ventures, Onos Health is deploying AI to read clinical notes, aiming to untangle the $140B behavioral health market.

Voya Energy unveils a system turning scrap aluminum into clean electricity, backed by a $35M Series A from top VCs. Can it solve the power crisis for data centers?

Series Entertainment's new platform, RUN, promises to collapse game development from years to days. But is this AI-native dream a true revolution for creators or just a new kind of assembly line?

With a $40M war chest, Quintessent is sampling a new comb laser that bypasses supply chain chokepoints and promises to slash AI data center power usage.

A new AI-designed eye drug gets clinical trial clearance, validating Matwings' iterative platform and signaling a major shift in biopharma R&D strategy.

With new Series A funding, TopHat Security is scaling its O-RANGE platform, letting critical infrastructure operators safely battle-test their defenses on digital replicas.

With a fresh $12.5M, RockRose Risk is vertically integrating to offer a radical solution to the West's wildfire insurance crisis: a one-stop-shop for risk assessment, mitigation, and coverage.

With a new $15M, Ours Privacy is tackling healthcare's biggest marketing challenge: growing without violating patient privacy in a strict regulatory world.

Velaura AI hits a $1B valuation with a $110M round, betting its proven low-power chips can solve the AI industry's escalating energy crisis.

With a $30M Series A, Mindgard is turning a decade of university research into a new defense against AI's unique and complex vulnerabilities.

Turnout's new AI platform, fronted by Steve Harvey, aims to unlock $140B in government benefits. Is this a tech-for-good revolution or a savvy business play?

River AI, led by an xAI co-founder, has secured $1.1B to build an open AI stack, aiming to shift AI ownership from big labs to individual companies.

With $15B in deals, Volta is treating AI compute like electricity, aiming to build a new utility for an industry constrained by capital, not just chips.

As legacy data protection fails in the AI era, ORION Security's rapid growth signals a market shift. Is their 'agentic' AI the answer to alert fatigue?

With a $17M Series A and Dot's Pretzels' former CEO Randy Johnson at the helm, The Farmer Companies is betting big on its plan to dominate the premium cheese snack market.

A $10M Series A fuels Discern's mission to automate a high-stakes, overlooked corner of corporate operations. Here's why investors see it as essential infrastructure.

A Columbus startup just raised $18M to exploit a flaw in employer healthcare, saving dual-income families thousands by turning a costly bug into a feature.

A new biotech, CORE Biomedicine, armed with Eisai's preclinical assets and a $21M Series A, aims to upend oncology by targeting cancer's 'lineage' identity.

With $21M in funding and a novel 'lineage-based' approach, CORE Biomedicine is moving beyond genomics to target the root cause of cancer's identity.

As AI-driven attacks operate at machine speed, one startup is betting $60M that reactive security is obsolete. Act Security aims to eliminate threats, not just find them.